Michael John Solon
Psychiatric/Mental Health · Edinburg, TXNPI 1295478337
Payments from drug & device makers
Across 310 payments — averaging $31.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Supernus Pharmaceuticals, Inc.$1K
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$950
- AbbVie$942
- plus $2K from 14 others
What the payments were for
- Food & beverage$9,722100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 28 | $1,478 |
| Teva Pharmaceuticals USA, Inc. | 43 | $1,459 |
| Supernus Pharmaceuticals, Inc. | 64 | $1,393 |
| Alkermes, Inc. | 37 | $1,139 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $950 |
| AbbVie | 38 | $942 |
| E.r. Squibb & Sons, L.L.C. | 10 | $552 |
| Corium, LLC | 21 | $437 |
| Axsome Therapeutics, Inc. | 6 | $227 |
| Collegium Pharmaceutical, Inc. | 8 | $225 |
| Vanda Pharmaceuticals Inc. | 3 | $156 |
| Ironshore Pharmaceuticals Inc. | 8 | $132 |
| Neurocrine Biosciences, Inc. | 6 | $126 |
| Melinta Therapeutics, LLC | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $101 |
| Johnson & Johnson | 3 | $65 |
| Tris Pharma Inc | 2 | $41 |
| Lundbeck LLC | 2 | $41 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,917
- ARISTADA$955
- REXULTI$598
- VRAYLAR$581
- QELBREE$473
- ABILIFY ASIMTUFII$376
- ABILIFY MAINTENA$376
- CAPLYTA$375
- COBENFY$351
- Austedo XR$350
- ARISTADA INITIO$239
- UZEDY$237
- Fanapt$125
- Rezzayo$125
- Auvelity$125
- KISUNLA$125
- Azstarys$115
- JORNAY PM$103
How this compares
$9,734 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 23 | $389 |
| Escitalopram Oxalate | 47 | $217 |
| Trazodone Hcl | 52 | $124 |
| Bupropion Hcl SrBupropion Hcl | 18 | $116 |
| Mirtazapine | 18 | $49 |
| Sertraline Hcl | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Edinburg
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.